Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma

Journal of Clinical Oncology

Volumn 16, Issue 11, 1998, Pages 3570-3575

  Friedman, Henry S ^a   Kokkinakis, Demetrius M ^a   Pluda, James ^a   Friedman, Allan H ^a   Cokgor, Ilkcan ^a   Haglund, Michael M ^a   Ashley, David M ^a   Rich, Jeremy ^a   Dolan, M Eileen ^a   Pegg, Anthony E ^a   Moschel, Robert C ^a   McLendon, Roger E ^a   Kerby, Tracy ^a   Herndon, James E ^a   Bigner, Darell D ^a   Schold Jr , S Clifford ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; CARMUSTINE; CHLOROETHYLNITROSOUREA; DEOXYRIBONUCLEOPROTEIN; LIQUID NITROGEN; NITROSOUREA DERIVATIVE; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOTOMY; DEMOGRAPHY; DNA REPAIR; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; LIPOPHILICITY; METHYLATION; PHASE 1 CLINICAL TRIAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TREATMENT PLANNING;

EID: 0031734148     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.11.3570     Document Type: Article

References (41)

1. Chang CH, Horton J, Schoenfeld D, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study. Cancer 52:997-1007. 1983
2. Green SB, Byar DP, Walker MD, et al: Comparisons of carmustine, procarbazine, and high-dose methylprednisiolone as additions to surgery and radiotherapy for treatment of malignant glioma. Cancer Treat Rep 67:121-132, 1983
3. Shapiro WR: Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13:38-45, 1986
4. Fine HA: The basis for current treatment recommendations for malignant gliomas. J Neurooncol 20:11 -120, 1994
5. 6-methylguanine DNA methyltransferase in cell survival, mutagenesis and carcinogenesis. Mutat Res 145:1-16, 1985
6. 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50:6119-6129, 1990
7. Ludlum DB: DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal. Mutat Res 233:117-126, 1990
8. 6-alkylguanine. FASEB J 6:2302-2310, 1992
9. Mitra S, Kaina B: Regulation of repair of alkylation damage in mammalian genomes. Prog Nucleic Acid Res Mol Biol 44:109-142, 1993
10. 6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51:167-223, 1995
11. 6-alkylguanine-DNA alkyl-transferase activity in human brain and brain tumors. Carcinogenesis 5:121-124, 1984
12. 6-alkylguannines. Cancer Res 45:6413-6417, 1985a
13. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87:5368-5372, 1990a
14. 6-benzylguanine and its effect on the sensitivity of human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. Cancer Commun 2:371-377, 1990b
15. 6-methylguanine. Carcinogenesis 12:2305-2309, 1991a
16. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 51:3367-3372, 1991b
17. 6-benzylguanine. Biochemistry 32:11998-12006, 1993
18. 6-Benzylguanine and its role in chemotherapy. Clin Cancer Res 8:837-847, 1997
19. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
20. LaBarca C, Paigen K: A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102:344-352, 1980
21. 6-methylguanine-DNA methyltransferase by methionine in human tumour cells. Br J Cancer 75:779-788, 1997
22. Schabel FM Jr, Johnston TP, McCaleb GS, et al: Experimental evaluation of potential anticancer agents. VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. Cancer 23:725-733, 1963
23. Levin VA: Chemotherapy of primary brain tumors. Neurol Clin 3:855-866, 1985
24. 6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain tumor xenografts. J Neurosurg 70:573-577, 1989
25. 6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications. J Neurooncol 21:135-140, 1994
26. Belanich M, Pastor M, Randall T, et al: Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 56:783-788, 1996
27. Zlotogorski C, Erickson LC: Pretreatment of human colon tumor cells with DNA methylating agents inhibits their activity to repair chloroethyl monoadducts. Carcinogenesis 5:83-87, 1984
28. Aida T, Bodell WJ: Cellular resistance to chloroethylnitro-soureas, nitrogen mustard, and cisdiamminedichloroplatinum (II) in human glial-derived lines. Cancer Res 47:1361-1366, 1987a
29. 6-alkylguanine-DNA alkyltransferase activity potentiates cytotoxicity and induction of SCEs in human glioma cells resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea. Carcinogenesis 8:1219-1223, 1987b
30. 6-methylguanine as a free base. Cancer Res 46:1663-1668, 1986
31. 6-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents. Biochem Biophys Res Commun 132:178-185, 1985b
32. 6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents. Cancer Res 46:4500-4504, 1986
33. 6-alkylguanine-DNA alkyltransferase. Cancer Res 48:1521-1527, 1988
34. 6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res 52:1171-1175, 1992
35. 6-methylguanine. Cancer Chemother Pharmacol 25:103-108, 1989
36. Friedman HS, Dolan ME, Moschel RC, et al: Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J Natl Cancer Inst 84:1926-1931, 1992
37. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother Pharmacol 32:471-476, 1993
38. Erickson LC, Bradley MO, Ducore JM, et al: DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proc Natl Acad Sci USA 77:467-471, 1980
39. 6-benzylguanine (BG) in patients with advanced cancer. Proc Am Assoc Clin Oncol, 15:176, 1996(abstr)
40. 6-alkylguanine DNA alkyltransferase directed DNA repair. Proc Am Assoc Clin Oncol 15:177, 1996 (abstr)
41. 6-benzylguanine in the treatment of central nervous system tumor xenografts. Cancer Res 55:2853-2857, 1995